Clinical Trials Logo

Biliary Complications clinical trials

View clinical trials related to Biliary Complications.

Filter by:
  • None
  • Page 1

NCT ID: NCT03048318 Completed - Clinical trials for Biliary Complications

Antegrade Arterial and Portal Flushing Versus Portal Flushing Only in LDLT

Start date: October 1, 2015
Phase: Phase 4
Study type: Interventional

Arterial flushing is a standard recommendation in deceased donor liver transplantation but not in living donor liver transplantation due to the risk of arterial intimal injury and short cold ischaemia time. There is recent evidence on benefit of retrograde arterial perfusion using hepatic venous occlusion and its benefits on post transplant cholestasis. However there is no data on antegrade arterial flushing.

NCT ID: NCT01829139 Recruiting - Clinical trials for Common Bile Duct Stones

Efficacy of Choleretics in Acalculous Gallbladder in Situ After Endoscopic Removal of Biliary Stones

Start date: March 2012
Phase: N/A
Study type: Observational [Patient Registry]

In patients with gallbladder in situ after complete removal of common bile duct (CBD) stones, there is no definite guideline for the management of remnant acalculous gallbladder. This study was planned to evaluate the efficacy of choleretic agents in those patients comparing with non-treatment group during short (2 years) and long-term (5 to 10 years) period. So that, the investigators want to establish the treatment guideline in gallbladder in situ without definite stones following complete removal of CBD stones. Second, the protective or preventive effect of choleretics may be defined.